AnalysisNews

SEM today

$16.51-$0.02 (-0.12%)close Jun 30, 2026

Trend

DailyUptrend (confirmed)

4 hourExpanding

1 hourBearish

15 minBearish

5 minNo data

Daily trend turns down below $12.61

Key levels

Resistance$16.70

Resistance$16.62

Support$16.41

Support$16.33

Latest news & SEC filings

EarningsSemperit Posts Profit and Higher Sales for First Three Quarters of 2026

NewsSemperit announces change in chief financial officer role

All SEM news →

· Healthcare

SELECT MEDICAL HOLDINGS CORP (SEM)

$16.51-0.02 (-0.12%)
HOLDGrade: CRisk: MEDIUM
1D5D1M1Y5YMaxSign up for all timeframes
16.5216.5516.5916.6216.51May 27Jun 4Jun 12Jun 23
High16.56
Low16.51
Open16.53
Volume25.23M
Avg Vol2.87M
VWAPN/A
30d High16.66
30d Low16.48
30d Chg+0.18%

What Is the Price Target for SEM?

SEPT Low Target

$14.03

SEPT Mid Target

$16.50

SEPT High Target

$18.97

Analyst Consensus

$16.50

Current: $16.51Upside: -0.1%Confidence: 40%Method: Analyst Consensus

Is SEM a Buy or Sell Right Now?

44
Investability Score
HOLD12-18 months

Thesis

  • •Revenue growing 5.1% YoY with STABLE trend — consistent growth.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for SEM.

Start Free Trial →

Is SEM Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

P/E Forward, P/B, Analyst Consensus

Fair Value

$18.70

20

Moat Score

NONE

5/9

Piotroski Score

1.6

Altman Z-Score

What Is Smart Money Doing with SEM?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

ACCUMULATING

Short Squeeze Risk

MEDIUM

Signal: NEUTRAL

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

SEM Growth Story

Revenue YoY

5.1%

3yr Revenue CAGR

N/A%

EPS Growth YoY

-30.12%

FCF Growth YoY

-60.4%

Revenue Trend

STABLE

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for SELECT MEDICAL HOLDINGS CORP (SEM) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (14 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

SEM — frequently asked questions

What is SEM stock price today?

SELECT MEDICAL HOLDINGS CORP (SEM) is at $16.51, down 0.12% (-$0.02) at the Jun 30, 2026 close.

Why is SEM stock moving today?

Latest SEM news — Nov 12, 2026: Semperit Posts Profit and Higher Sales for First Three Quarters of 2026 · Oct 22, 2026: Semperit announces change in chief financial officer role

What is the SEM price target?

The average analyst price target for SEM is $16.50, ranging from $17 to $17, based on 1 analysts. Latest: Mizuho downgrade on May 13, 2026.

What do analysts rate SEM?

Analyst ratings for SEM: 0 Buy, 0 Hold, 1 Sell — consensus Sell.

Did SEM beat earnings?

SEM last reported on Apr 30, 2026: EPS $0.36 vs $0.43 expected — a miss of 16.3%.

What is SEM's P/E ratio?

SEM trades at a P/E of 14.3.

Does SEM pay a dividend?

Yes. SEM's dividend yield is 1.71%.

How much debt does SEM have?

SELECT MEDICAL HOLDINGS CORP reported $1.8B of debt and $26M of cash (Mar 31, 2026).

What are SEM support and resistance levels?

Support: $16.41, $16.33, $15.80. Resistance: $16.62, $16.70, $16.99.

What are insiders doing with SEM?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on SEM?

Nov 12, 2026: Semperit Posts Profit and Higher Sales for First Three Quarters of 2026 · Oct 22, 2026: Semperit announces change in chief financial officer role